Our primary investment interests are in start-up companies developing medical device and diagnostic products that address major diseases and conditions prevalent in industrialized countries as the population ages (such as cancer, cardiovascular and neurological diseases, orthopedic problems, respiratory conditions, and gastrointestinal disorders).  

In these areas, we favor companies with novel, single-use medical devices that can provide clinically efficacious therapy, at lower cost, compared to conventional approaches, and with manageable and acceptable regulatory and reimbursement risks.  We look for start-up opportunities featuring product concepts that can be advanced with minimal infrastructure and head-count – companies that can demonstrate clinical efficacy of their product or technology early on (with limited investment), and thus create strong potential for partnership and acquisition.

For independent buyside analysis and advice to healthcare investors in the publicly-traded biotechnology and medical device sectors, Synergy is proud to recommend FOURSQUARE PARTNERS.